Odisha logs record 45 coronavirus fatalities, 5,896 new infections

Caseload is at 825,110

Coronavirus testing
Coronavirus testing | File photo
Press Trust of India Bhubaneswar
2 min read Last Updated : Jun 08 2021 | 3:05 PM IST

Odisha on Tuesday registered

5,896 new COVID-19 cases, pushing the caseload to 8,25,110, while 45 fatalities, the highest so far in a single day, raised the toll to 3,080, a health department official said.

The case fatality ratio (CFR) stands at 0.37 per cent, which is one of the lowest in the country, he said.

Of the 5,896 new cases, 3,332 were recorded in quarantine centres, and the rest were detected during contact tracing, the official said.

Odisha currently has 74,172 active cases, he said.

Khurda district, of which the state capital Bhubaneswar is a part, reported the maximum number of new cases at 853, followed by Jajpur at 413, Angul at 385, Balasore at 373, Bhadrak at 370 and Cuttack at 349.

As many as 12 districts reported less than 100 cases, each, the lowest being 22 in Deogarh.

Districts bordering Chhattisgarh, which had emerged as the hotspot during the initial phase of the pandemic, has witnessed a considerable decline in caseload - some of them being Bargarh (99), Sambalpur (92), Bolangir and Sonepur (77 each), Boudh (73), Kandhamal (65), Jharsuguda (54).

Khurda district accounted for six fresh fatalities, followed by Cuttack and Kahalandi at five casualties each, and Angul, Dhenkanal, and Sundergarh at four each.

As many as 7,47,805 people, including 8,429 on Monday, have recuperated from the disease.

The coastal state's positivity has touched 6.3 per cent, the official said.

Over 1.23 crore sample tests have been conducted in the state, including 68,896 on Monday, he added.

Meanwhile, sources in the health department said that Odisha is unlikely to proceed on its plan to procure 3.8 crore COVID-19 vaccines after Prime Minister Narendra Modi on Monday announced that the Centre will supply vaccines to the states for all adults above 18 years of age.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus TestsCoronavirus Vaccine

First Published: Jun 08 2021 | 3:02 PM IST

Next Story